NCT01165645 2022-12-01
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
Mayo Clinic
Phase NA Withdrawn
Mayo Clinic
University of Arizona
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba